about
Social, clinical and microbiological differential characteristics of tuberculosis among immigrants in SpainFactors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis TreatmentA predictive scoring instrument for tuberculosis lost to follow-up outcome.Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment.Diagnosis and Treatment of Drug-Resistant Tuberculosis.Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.Non-Tuberculous Mycobacteria. An Emerging Threat?Utility of Phenotypic and Genotypic Testing in the Study of Mycobacterium tuberculosis Resistance to First-Line Anti-Tuberculosis drugs.Executive Summary of the Guidelines for the Use of interferon-gamma Release Assays in the Diagnosis of Tuberculosis Infection.Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection.Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.[Chronic pulmonary histoplasmosis diagnosed in a nonimmunosuppressed patient 10 years after returning from an endemic area].Cleaning at Home and at Work in Relation to Lung Function Decline and Airway Obstruction.Airways reactivity, atopy and bronchoalveolar lavage in male smokers with airflow obstruction.[Lymphangio-leiomyomatosis. Apropos of a case]Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma[Pulmonary interstitial disease due to hemochromatosis as a presenting sign of disease][Spontaneous pneumothorax as the only initial manifestation of bronchogenic carcinoma]Immunodetection of pneumolysin in human urine by ELISA[Respiratory infections caused by environmental mycobacteria]Prevention and treatment of tuberculosis infection in candidates for biologic therapy: A multidisciplinary consensus statement adapted to the dermatology patientSurveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportShortage of Fixed-Dose Combination of Antituberculous Drugs in SpainEvaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years onOrganization of Tuberculosis Control in Spain: Evaluation of a Strategy Aimed at Promoting the Accreditation of Tuberculosis UnitsSurveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyTuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohortsActive tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
P50
Q28476792-2964D812-1062-4441-B0A3-D4230AA514EAQ36093920-E9B22229-B28E-444E-9A62-1C8F2990C62BQ36376863-A394C40A-4D86-4000-B6A9-98C4C8610D45Q38549703-D19F275C-46FC-4CBC-8078-25BEB83ECD50Q38737561-E4A1C681-0742-4659-9CB7-C9340220AA5EQ38915347-00F48E7F-09D2-4A00-8BEF-E6ED99A83E5AQ40241563-D75876BD-F291-4097-8B39-F89E44691EDFQ40300312-C68DCE7A-9C37-4D49-9D10-93953992173AQ40611080-9493E6BD-EB42-423B-B851-BFD89372A5DAQ40776957-1DC1D43C-4325-41E3-8E4C-72C90D5A03A3Q41436229-ACB864FF-30A2-4385-9D5A-83C2F142B9AAQ46248937-D16B1901-95D4-487F-A462-5B993BEC020AQ49935537-E9F355BF-F3D4-4D73-ABA5-2C05D1BEEFCDQ51008773-F0CCCB79-C761-4EC5-A60C-02FC1AA4DD19Q68440217-8FE1FA69-798E-40F8-A044-50EC4B773641Q70872145-8EEC7ABF-8394-463F-95D0-52CA39C40A47Q72609300-2091A4C8-A86C-4D40-9771-EDE64BA6FDCEQ72859831-BC8DD3A4-9E51-4B5F-AE38-A51BD905A9CDQ73355754-8BD635F0-E0DB-4FC2-9641-B0C69914A1E4Q81643225-D484048C-0D1C-469D-AFE3-32D18A504D1AQ88999466-7057B4F6-EA84-4F9E-A075-4E483041BD5CQ90638905-95472201-0E36-4437-9EF7-C6D1F32EA7FDQ91060004-9672624E-9888-428F-8419-EE8A7E73BA14Q91522672-CE979F80-C6F7-4ED2-AA6A-5CB5AC6C8552Q92570029-69532F6E-F89F-4FF0-BB1D-17314FB33888Q92891736-C89C5791-0FA0-4E65-9D63-E0E109971864Q94928480-DE115FF4-16C3-4C73-BA35-5B2E8D290C29Q95838865-3D99C38E-AF3D-4382-81A0-3A05FF7B187F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
José-María García-García
@ast
José-María García-García
@en
José-María García-García
@es
José-María García-García
@nl
type
label
José-María García-García
@ast
José-María García-García
@en
José-María García-García
@es
José-María García-García
@nl
prefLabel
José-María García-García
@ast
José-María García-García
@en
José-María García-García
@es
José-María García-García
@nl
P106
P21
P31
P496
0000-0002-2809-6230